Some aspects of mutant p53 in ovarian cancer biology
Epithelial ovarian cancer (EOC) is known as the most lethal gynaecologic malignancy. The poor prognosis of EOC has been attributed to e.g., late diagnosis of the disease and to chemoresistance. Further, we are still missing biomarkers that may reliably predict prognosis or chemosensitivity of an ind...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
21 September 2016
|
| In: |
Translational cancer research
Year: 2016, Volume: 3, Pages: S546-S547 |
| ISSN: | 2219-6803 |
| DOI: | 10.21037/tcr.2016.09.21 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.21037/tcr.2016.09.21 Verlag, kostenfrei, Volltext: http://tcr.amegroups.com/article/view/9625/html 
|
| Author Notes: | Sabine Heublein |
| Summary: | Epithelial ovarian cancer (EOC) is known as the most lethal gynaecologic malignancy. The poor prognosis of EOC has been attributed to e.g., late diagnosis of the disease and to chemoresistance. Further, we are still missing biomarkers that may reliably predict prognosis or chemosensitivity of an individual patient. |
|---|---|
| Item Description: | Gesehen am 03.01.2018 |
| Physical Description: | Online Resource |
| ISSN: | 2219-6803 |
| DOI: | 10.21037/tcr.2016.09.21 |